MXPA03008033A - Composicion medicinal que contiene derivados de 1,3-tiazina. - Google Patents

Composicion medicinal que contiene derivados de 1,3-tiazina.

Info

Publication number
MXPA03008033A
MXPA03008033A MXPA03008033A MXPA03008033A MXPA03008033A MX PA03008033 A MXPA03008033 A MX PA03008033A MX PA03008033 A MXPA03008033 A MX PA03008033A MX PA03008033 A MXPA03008033 A MX PA03008033A MX PA03008033 A MXPA03008033 A MX PA03008033A
Authority
MX
Mexico
Prior art keywords
composition containing
medicinal composition
thiazine derivative
optionally substituted
thiazine
Prior art date
Application number
MXPA03008033A
Other languages
English (en)
Inventor
Kai Hiroyuki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of MXPA03008033A publication Critical patent/MXPA03008033A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/041,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/061,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10Spiro-condensed systems
MXPA03008033A 2001-03-08 2002-02-14 Composicion medicinal que contiene derivados de 1,3-tiazina. MXPA03008033A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001065386 2001-03-08
PCT/JP2002/001229 WO2002072562A1 (fr) 2001-03-08 2002-02-14 Preparation medicinale contenant un derive de 1,3-thiazine

Publications (1)

Publication Number Publication Date
MXPA03008033A true MXPA03008033A (es) 2003-12-04

Family

ID=18924048

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03008033A MXPA03008033A (es) 2001-03-08 2002-02-14 Composicion medicinal que contiene derivados de 1,3-tiazina.

Country Status (11)

Country Link
US (1) US6916806B2 (es)
EP (1) EP1375489B1 (es)
JP (1) JP4188694B2 (es)
KR (2) KR100642570B1 (es)
CN (1) CN1301981C (es)
AT (1) ATE405555T1 (es)
BR (1) BR0207966A (es)
CA (1) CA2440186C (es)
DE (1) DE60228429D1 (es)
MX (1) MXPA03008033A (es)
WO (1) WO2002072562A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6877300A (en) * 1999-09-14 2001-04-17 Shionogi & Co., Ltd. 2-imino-1,3-thiazine derivatives
WO2003070277A1 (fr) * 2002-02-19 2003-08-28 Shionogi & Co., Ltd. Antiprurigineux
WO2005016351A1 (ja) * 2003-08-18 2005-02-24 Shionogi & Co., Ltd. カンナビノイド受容体アゴニストの新規用途
TW200508211A (en) * 2003-08-26 2005-03-01 Shionogi & Co 2-naphthylimino-1,3-thiazine derivatives
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
WO2006080284A1 (ja) * 2005-01-25 2006-08-03 Shionogi & Co., Ltd. 2-置換イミノ-1,3-オキサジン誘導体
JPWO2006080287A1 (ja) * 2005-01-25 2008-06-19 塩野義製薬株式会社 2−アゾリルイミノ−1,3−チアジン誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165894A (ja) 1984-09-08 1986-04-04 Shionogi & Co Ltd チアジンホスホン酸誘導体とその製法および殺虫剤
JPS6229594A (ja) 1985-07-31 1987-02-07 Shionogi & Co Ltd チアジン環を有する有機燐化合物
JPS62120374A (ja) * 1985-11-20 1987-06-01 Yoshitomi Pharmaceut Ind Ltd 1,3−チアジンまたは1,3−オキサジン誘導体
NL8702437A (nl) 1987-10-13 1989-05-01 Geo Kinetics B V I O Werkwijze voor het conditioneren van grondmateriaal door elektrokinetische behandeling, elektrisch stroomsysteem voor toepassing van de werkwijze alsmede elektrode-behuizing voor toepassing in het elektrische stroomsysteem.
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5194434A (en) * 1991-12-03 1993-03-16 Texas A&M University System Use of OB-101 to treat ocular inflammation
KR19990082330A (ko) * 1996-02-06 1999-11-25 미즈노 마사루 신규 화합물 및 이의 의약 용도
WO1998041519A1 (en) 1997-03-18 1998-09-24 Smithkline Beecham Corporation Novel cannabinoid receptor agonists
AU8127998A (en) 1997-07-11 1999-02-08 Japan Tobacco Inc. Quinoline compounds and medicinal uses thereof
DE19837627A1 (de) * 1998-08-19 2000-02-24 Bayer Ag Neue Aminosäureester von Arylsulfonamiden und Analoga
EP1144396A2 (en) 1999-01-14 2001-10-17 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
AU6877300A (en) * 1999-09-14 2001-04-17 Shionogi & Co., Ltd. 2-imino-1,3-thiazine derivatives

Also Published As

Publication number Publication date
CA2440186C (en) 2009-01-13
CN1514831A (zh) 2004-07-21
EP1375489A1 (en) 2004-01-02
JP4188694B2 (ja) 2008-11-26
BR0207966A (pt) 2004-06-15
EP1375489A4 (en) 2005-03-02
WO2002072562A1 (fr) 2002-09-19
KR20040007462A (ko) 2004-01-24
EP1375489B1 (en) 2008-08-20
KR100642570B1 (ko) 2006-11-10
US20040116326A1 (en) 2004-06-17
JPWO2002072562A1 (ja) 2004-07-02
DE60228429D1 (de) 2008-10-02
CA2440186A1 (en) 2002-09-19
ATE405555T1 (de) 2008-09-15
KR20060029296A (ko) 2006-04-05
CN1301981C (zh) 2007-02-28
US6916806B2 (en) 2005-07-12

Similar Documents

Publication Publication Date Title
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
AU1282495A (en) Anthranilic acid derivative
CA2335285A1 (en) Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
HK1046639A1 (en) Nitroimidazole external preparations for dermatosis
AU6877300A (en) 2-imino-1,3-thiazine derivatives
EP1190710A4 (en) PREVENTIVE OR THERAPEUTIC MEDICATIONS FOR DIABETES
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
PT918776E (pt) Sintese total de acilfulvenos antitumorais
PE34996A1 (es) Nuevo derivado de pirrocarbazol
DK1031556T3 (da) 2-phenoxyanilinderivater
EP1375489A4 (en) MEDICINAL PREPARATION CONTAINING A 1,3-THIAZINE DERIVATIVE
DK1559714T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater
EP1211253A4 (en) DIHYDROBENZOFURAN TRICYCLIC DERIVATIVES, THEIR PREPARATION METHOD AND AGENTS
EP1241166A4 (en) 3-MEHTYL CHROMAN AND THIOCHROME DERIVATIVES
EP0230474A4 (en) BIS-DIOXOPIPERAZINE COMBATS AND MEDICINAL PRODUCTS THEREOF.
EP1241167A4 (en) DERIVATIVES OF 3-ETHYL-, 3-PROPYL-, OR 3-BUTYL-CHROMANE AND -THIOCHROMANE
GR3004321T3 (es)

Legal Events

Date Code Title Description
FG Grant or registration